Beneficient 8-K filings
NASDAQ
BENF
BeneficientBeneficient's Chief Executive Officer and Chairman, Brad Heppner, has resigned effective immediately following his refusal to cooperate with an Audit Committee inquiry into his relationship with a related entity and a dispute over potential disclosures.
NASDAQ
BENF
Beneficient8-K: Beneficient Secures $1.91 Million Primary Capital Through New Convertible Preferred Stock Issuance
Beneficient has successfully closed a $1.91 million primary capital transaction by issuing Series B-8 Resettable Convertible Preferred Stock, expanding its alternative asset financing solutions.
NASDAQ
BENF
BeneficientBeneficient announced that the Bankruptcy Court has approved the settlement agreement resolving all claims in the GWG Holdings, Inc. litigation against the company and its parties, subject to a 14-day appeal period and District Court approval.
NASDAQ
BENF
BeneficientBeneficient announced the immediate termination of its previously disclosed Stock Purchase Agreement to acquire Mercantile Bank International Corp., with no additional liability incurred by Beneficient.
NASDAQ
BENF
BeneficientBeneficient announced that its stockholders approved the election of seven directors and the ratification of Weaver and Tidwell, LLP as its independent registered public accounting firm at the 2025 annual meeting, which had been adjourned multiple times.
NASDAQ
BENF
BeneficientBeneficient has closed a primary capital transaction, providing $233,333 to Cork & Vines Fund I, LP in exchange for shares of the company's Resettable Convertible Preferred Stock.
NASDAQ
BENF
Beneficient8-K: Beneficient Closes $9.6 Million GP Primary Capital Transaction, Issues Convertible Preferred Stock
Beneficient closed a $9.6 million primary capital transaction, issuing Series B-6 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund.
NASDAQ
BENF
BeneficientBeneficient announces a subscription agreement with Hatteras Master Fund and settles all claims in the GWG Litigation, resolving disputes without admitting fault and focusing on future growth.
NASDAQ
BENF
BeneficientBeneficient announces the date for its 2025 annual meeting of stockholders and related deadlines for shareholder proposals and director nominations.
NASDAQ
BENF
BeneficientBeneficient reports increased revenues and decreased operating expenses for Q3 2025, alongside announcing a proposed transaction to increase tangible book value and an international bank acquisition.
NASDAQ
BENF
BeneficientBeneficient is providing an investor presentation to be used at the Sequire Investor Summit on January 22, 2025.
NASDAQ
BENF
BeneficientBeneficient has received a notice from Nasdaq stating that its share price has fallen below the minimum required for continued listing.
NASDAQ
BENF
Beneficient8-K: Beneficient Closes $1.36 Million Primary Capital Transaction, Issues Series B-5 Preferred Stock
Beneficient closed a $1.36 million primary capital transaction, issuing Series B-5 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund.
NASDAQ
BENF
BeneficientBeneficient has entered into a master agreement to amend its subsidiary's governing documents, allowing public stockholders to share in liquidation priority and creating tangible book value.
NASDAQ
BENF
Beneficient8-K: Beneficient to Acquire Mercantile Bank International, Expanding Alternative Asset Custody Services
Beneficient has agreed to acquire Mercantile Bank International for $1.5 million in a mix of stock and cash, aiming to broaden its custody services and tap into new international markets.
NASDAQ
BENF
BeneficientBeneficient has released an investor presentation to be used at the Emerging Growth Conference on December 4, 2024.
NASDAQ
BENF
BeneficientBeneficient has received confirmation from Nasdaq that it has regained compliance with both the minimum stockholders' equity and audit committee requirements, allowing its securities to continue trading on the exchange.
NASDAQ
BENF
BeneficientBeneficient appointed Karen Wendel to its board of directors and increased its permanent equity by $35 million through a redesignation of preferred shares, aiming to regain compliance with Nasdaq listing requirements.
NASDAQ
BENF
BeneficientBeneficient announced its second consecutive profitable quarter as a public company, with increased revenues and a strengthened balance sheet.
NASDAQ
BENF
BeneficientBeneficient is providing an investor presentation at the LD Micro Main Event XVII Conference on October 30, 2024.
NASDAQ
BENF
BeneficientBeneficient terminated a forward purchase agreement with RiverNorth and increased its authorized Class A common stock shares to 5 billion.
NASDAQ
BENF
BeneficientBeneficient reclassified approximately $126 million of temporary equity to permanent equity and appointed Patrick J. Donegan to its Board of Directors.
NASDAQ
BENF
BeneficientBeneficient sold 150,000 shares of its Class A common stock to Cangany Capital Management, a firm controlled by a board member, in a private transaction.
NASDAQ
BENF
Beneficient8-K: Beneficient Submits Plan to Regain Nasdaq Compliance After Falling Below Minimum Equity Requirement
Beneficient has submitted a plan to Nasdaq to regain compliance with minimum equity requirements by reclassifying $125.5 million of temporary equity to permanent equity.
NASDAQ
BENF
BeneficientBeneficient has raised $325,000 through the sale of Class A common stock to board members via private placements.
NASDAQ
BENF
BeneficientBeneficient has amended its credit agreement to include an additional term loan of up to $1.675 million and to waive certain defaults.
NASDAQ
BENF
BeneficientBeneficient released an investor presentation in connection with its participation at the Sidoti Micro-Cap Conference on August 15, 2024.
NASDAQ
BENF
BeneficientBeneficient achieved its first profitable quarter as a public company in Q1 2025, driven by improved financial results and the launch of a new automated pricing system.
NASDAQ
BENF
BeneficientBeneficient has entered into a securities purchase agreement for a private placement of up to $4 million in convertible debentures and warrants.
NASDAQ
BENF
BeneficientA Texas court has vacated a $55.3 million arbitration award against Beneficient, a financial services company.